Background Researchers have suggested that omega‐3 polyunsaturated fatty acids from
oily fish (long‐chain omega‐3 (LCn3), including eicosapentaenoic acid (EPA) and …

Background Evidence on the health effects of total polyunsaturated fatty acids (PUFA) is
equivocal. Fish oils are rich in omega‐3 PUFA and plant oils in omega‐6 PUFA. Evidence …

There is no licensed treatment for nonalcoholic fatty liver disease (NAFLD), a condition that
increases risk of chronic liver disease, type 2 diabetes, and cardiovascular disease. We …

For many years it has been known that high doses of long chain omega-3 fatty acids are
beneficial in the treatment of hypertriglyceridaemia. Over the last three decades, there has …

Background Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome with the main
characteristic of diffuse liver cells with fatty changes. The clinical evolution of NAFLD …

Context Treatment options for nonalcoholic fatty liver disease (NAFLD) are needed.
Objective The aim of this review was to systematically assess the effects of omega-3 long …

Following the epidemics of obesity, nonalcoholic fatty liver disease (NAFLD) has become
the leading cause of liver disease in western countries. NAFLD is the hepatic manifestation …

Poor dietary composition is an important factor in the progression of non-alcoholic fatty liver
disease (NAFLD). The majority of NAFLD patients follow diets with overconsumption of …

Background & Aims Genetic variation in both patatin-like phospholipase domain-containing
protein-3 (PNPLA3)(I148M) and the transmembrane 6 superfamily member 2 protein …

Objective Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying
cause in the development of nonalcoholic fatty liver disease and/or insulin resistance. It is …